Pharmaceutical Preparations - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Pharmaceutical industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Pharmaceutical Preparations - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Pharmaceutical Preparations
Corporate Insider Buy Sell Ratio (Insider Count) - Pharmaceutical Preparations
Pharmaceutical Preparations - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4535 -2,121
2025-09-17 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4892 -362,806
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.9702 -3,135
2025-09-17 ELVN / Enliven Therapeutics, Inc. 4 Kintz Samuel S - Sale I 19.0946 -5,000
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Koenig Sheldon L. S - Sale D 2.788 -28,427
2025-09-17 ALXO / ALX Oncology Holdings Inc. 4 Lettmann Jason P - Purchase D 1.0805 71,163
2025-09-17 IMMX / Immix Biopharma, Inc. 4 Rachman Ilya M P - Purchase D 2.02 2,500
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-17 PGEN / Precigen, Inc. 4 KIRK RANDAL J by R.J. Kirk DOT M - Exercise I 17,385,257
2025-09-17 NRIX / Nurix Therapeutics, Inc. 4 GREGORY JULIA P M - Exercise D 1.86 10,750
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC C - Conversion I 2.32 100,000
2025-09-16 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.5332 -192,293
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 21.3333 -7,430
2025-09-16 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.5332 -307,707
2025-09-16 TNGX / Tango Therapeutics, Inc. 4 Third Rock Ventures IV, L.P. S - Sale D 7.04 -363,541
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.281 -1,000
2025-09-16 APLS / Apellis Pharmaceuticals, Inc. 4 Watson David O. S - Sale D 24.34 -5,000
2025-09-16 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 Accardi Mario Alberto S - Sale D 22.0213 -742
2025-09-16 VSTM / Verastem, Inc. 4 Stuglik Brian M S - Sale D 9.99 -587
2025-09-16 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.88 -840
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 400.5937 -3,000
2025-09-16 MNKD / MannKind Corporation 4 Tross Stuart A S - Sale D 5.34 -47,000
2025-09-16 VSTM / Verastem, Inc. 4 Gagnon Robert E. S - Sale D 9.99 -281
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 327.78 -400
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 116.19 -5,783
2025-09-16 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale D 8.04 -10,000
2025-09-16 VSTM / Verastem, Inc. 4 Paterson Dan S - Sale D 9.99 -390
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 TABUTEAU HERRIOT S - Sale D 114.19 -19,719
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 326.9029 -4,008
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 325.062 -6,883
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 114.23 -40,000
2025-09-16 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale I 8.08 -1,914
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 324.1176 -4,066
2025-09-16 ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) 4 OYLER JOHN S - Sale D 326.1362 -12,446
2025-09-16 IMMX / Immix Biopharma, Inc. 4 Morris Gabriel S P - Purchase D 1.97 2,600
2025-09-16 ALXO / ALX Oncology Holdings Inc. 4 Lettmann Jason P - Purchase D 1.066 21,070
2025-09-16 LFVN / LifeVantage Corporation 4 Lewis Darwin P - Purchase D 10.8499 450
2025-09-16 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-16 CRMD / CorMedix Inc. 4 Duncan Gregory Scott M - Exercise D 8.32 13,333
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 TABUTEAU HERRIOT M - Exercise D 8.02 19,719
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.85 15,000
2025-09-16 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 4.95 25,000
2025-09-16 PTGX / Protagonist Therapeutics, Inc. 4 PATEL DINESH V PH D G - Gift D -620
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 79.30 -16,080
2025-09-15 NUVL / Nuvalent, Inc. 4 Porter James Richard S - Sale D 78.42 -8,823
2025-09-15 MLYS / Mineralys Therapeutics, Inc. 4 Rodman David Malcom S - Sale D 36.4748 -2,065
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Mano Michael S - Sale D 6.43 -234
2025-09-15 KPTI / Karyopharm Therapeutics Inc. 4 Cheng Sohanya Roshan S - Sale D 6.43 -325
2025-09-15 RNA / Avidity Biosciences, Inc. 4 Hughes Steven George S - Sale D 45.41 -1,542
2025-09-15 CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 4 HUSSAIN IQBAL J S - Sale D 21.8501 -6,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)